Subscribe To
sorrento distributes dividend confirmation statements to 146 brokerage firms and provides specific instruction to continental stock transfer & trust company regarding the dividend of scilex holding co
SAN DIEGO, Feb. 03, 2023 (GLOBE NEWSWIRE) — sorrento Therapeutics, Inc. (Nasdaq: SRNE, “...
February 4, 2023, 1:59 am
sorrento distributes dividend confirmation statements to 146 brokerage firms and provides specific instruction to continental stock transfer & trust company regarding the dividend of scilex holding co
SAN DIEGO, Feb. 03, 2023 (GLOBE NEWSWIRE) — sorrento Therapeutics, Inc. (Nasdaq: SRNE, “...
February 4, 2023, 1:59 am
sorrento issues supplement to its previously issued “faq” regarding the dividend of scilex holding company common stock
SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) — sorrento Therapeutics, Inc. (Nasdaq: SRNE, “...
February 2, 2023, 7:12 pm
Scilex holding company announces that its majority stockholder, sorrento therapeutics, inc., has issued a supplement to its previously issued “faq” regarding the dividend of scilex holding company com
PALO ALTO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, ...
February 2, 2023, 6:15 pm
sorrento issues “faq” regarding the dividend of scilex holding company common stock
SAN DIEGO, Jan. 29, 2023 (GLOBE NEWSWIRE) — sorrento Therapeutics, Inc. (Nasdaq: SRNE, “...
January 30, 2023, 3:27 am
Scilex holding company announces that its majority stockholder, sorrento therapeutics, inc., has issued an “faq” regarding the dividend of scilex holding company common stock
PALO ALTO, Calif., Jan. 29, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, ...
January 30, 2023, 2:55 am
A spac, spinoff, and short squeeze walk into a bar
Shares of Scilex could trade higher due to hedging pressure from large sorrento short positions. Scilex...
January 24, 2023, 3:30 pm
sorrento therapeutics, scilex: 2 hot pharma stocks on the move
sorrento Therapeutics is on the move following preliminary results from its subsidiary Scilex. Scilex i...
January 13, 2023, 12:46 pm
sorrento to host webcast to discuss newly presented clinical data demonstrating significant improvements in therapeutic outcomes in 10 of 10 patients with poorly controlled rheumatoid arthritis
ATLANTA and SAN DIEGO, Nov. 13, 2022 (GLOBE NEWSWIRE) — Sofusa®, a wholly-owned division of sorrento...
November 13, 2022, 8:02 pm
sorrento to host webcast to discuss newly presented clinical data demonstrating significant improvements in therapeutic outcomes in 10 of 10 patients with poorly controlled rheumatoid arthritis
ATLANTA and SAN DIEGO, Nov. 13, 2022 (GLOBE NEWSWIRE) -- Sofusa®, a wholly-owned division of sorrento ...
November 13, 2022, 3:02 pm
sorrento: limited potential, high management compensation, complicated lawsuits
sorrento Therapeutics has been in the limelight for all the wrong reasons. Its R&D is just a byproduct ...
November 9, 2022, 2:29 pm
Positive abivertinib trial results push sorrento therapeutics (srne) 6.2% higher
Biopharmaceutical outfit sorrento Therapeutics (US:SRNE) rallied +6.2% on Tuesday and extended gains by...
August 24, 2022, 9:12 pm
sorrento therapeutics: the enigma
sorrento's outsized ambitions are not playing well for shareholders. ...
July 15, 2022, 12:48 am
Why ocugen, sorrento therapeutics, and vbi vaccines are on the move today
Healthcare has become a bona fide stock picker's market this year....
July 14, 2022, 12:30 pm
Why sorrento therapeutics stock is jumping today
The biotech's bargain-basement valuation appears to be attracting investors' interest....
July 5, 2022, 11:32 am
sorrento starts mid-stage study of abivertinib in prostate cancer
The FDA has signed off sorrento Therapeutics Inc's (NASDAQ: SRNE) investigational new drug applicati...
May 17, 2022, 4:05 pm
Why sorrento therapeutics stock shot 7% higher today
The company delivers some encouraging news about a COVID drug....
May 2, 2022, 6:54 pm
Fda gives green signal to human trial for sorrento's sti-9167 against omicron
The FDA has cleared sorrento Therapeutics Inc's (NASDAQ: SRNE) investigational new drug application�...
April 25, 2022, 4:15 pm
City office reit: the definition of shareholder value
The company recently entered into an agreement for the sale of its sorrento Mesa assets and used the pr...
March 25, 2022, 10:16 am
sorrento's chimeric mrna covid-19 vaccine candidate shows preclinical action against omicron variants
sorrento Therapeutics Inc (NASDAQ: SRNE) announced the publication of a preprint entitled "Chimeric ...
March 21, 2022, 10:20 am